FDA Inspection
Ibrahim Amjad, M.D.Ibrahim Amjad, M.D. – FDA Inspection, Jul 28, 2021
Record Details
This FDA Inspection record concerns Ibrahim Amjad, M.D., with an inspection on July 28, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ibrahim Amjad, M.D.
- Inspection Date
- July 28, 2021
- Product Type
- Drugs
View Company Profile
ID · 7197a711-2e6f-4029-a158-444e0aa23d03
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1147260
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.